| APPBP2 Protein | |
|---|---|
| Protein Name | APPBP2 (Amyloid Precursor Protein Binding Protein 2) |
| Gene | APPBP2 |
| UniProt | Q92688 |
| Molecular Weight | 59 kDa |
| Subcellular Localization | Cytoplasm, Golgi apparatus, Cytoskeleton |
| Protein Family | BTB/Kelch family |
| Aliases | PAT1, KIBRA (in some contexts) |
Appbp2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
APPBP2 (Amyloid Precursor Protein Binding Protein 2) is a cytoplasmic protein that binds to the cytoplasmic tail of Amyloid Precursor Protein (APP). Also known as PAT1, APPBP2 is involved in intracellular trafficking of APP and may modulate its processing through the amyloidogenic and non-amyloidogenic pathways [1].
The protein is expressed in various tissues, with high expression in brain, particularly in regions involved in learning and memory. APPBP2 contains multiple protein-protein interaction domains that enable it to function as an adaptor protein.
APPBP2 contains several functional domains:
The primary function of APPBP2 is to modulate APP subcellular localization:
By altering APP trafficking, APPBP2 influences which secretases have access to APP:
APPBP2 may play a protective role in AD:
APPBP2 has been implicated in cancer biology through its interaction with other proteins. The protein may function as a tumor suppressor in some contexts.
APPBP2 represents a potential therapeutic target for AD:
The study of Appbp2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.